Advisor Group Holdings, Inc. Cardiol Therapeutics Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,744 shares of CRDL stock, worth $3,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,744
Previous 1,200
212.0%
Holding current value
$3,631
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CRDL
# of Institutions
45Shares Held
7.58MCall Options Held
4.9KPut Options Held
3.8K-
Tejara Capital LTD London, X03.12MShares$3.02 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD882KShares$856,0130.23% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$771,7560.31% of portfolio
-
Pvg Asset Management Corp Golden, CO487KShares$472,6763.54% of portfolio
-
Lion Street Advisors, LLC334KShares$323,7130.11% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $60.1M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...